ARCTArcturus Therapeutics Holdings Inc.

$6.82-49% 1Y

What is the market doing?

Good

In an uptrend. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data
TrendUptrendderived · Oct 8, 2026

In an uptrend, above its rising 50- and 200-day averages. Price is +49% vs its 200-day average.

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How ARCT is trading

Arcturus Therapeutics Holdings Inc. is −49% over the past year while the S&P 500 is +18%: 67 points behind the market.

−49%

1-year return · S&P 500 +18%

vs 200-day average
+49%

vs 200-day average · a clear uptrend

RSI (14)
33

RSI (14) · neutral

Below its 52-week high
45%

Below its 52-week high

Oct 4, 2024$5.52 – $28.98 · dashed line: 200-day averageOct 8, 2026
Details›
Last close2026-10-08
$6.82
1 monthS&P 500 +1.6%
−5.4%
1 yearS&P 500 +18%
−49%
5 yearsS&P 500 +86%
−80%
vs 50-day average$12.39
+3.6%
52-week high
$23.16
52-week low
$5.52
Annualised volatility
87%
Calendar-year price return
YearReturn
2026 (year to date)+109%
2025−64%
2024−46%
2023+86%
2022−54%
2021−15%
2020+299%
2019+140%
2018−43%
2017−46%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan105 of 10+4.1%
Feb105 of 10+0.02%
Mar103 of 10+0.13%
Apr106 of 10+14%
May105 of 10+4.3%
Jun107 of 10+5.1%
Jul114 of 11+4.2%
Aug115 of 11+19%
Sep114 of 11−6.8%
Oct114 of 11−5.4%
Nov106 of 10+5.5%
Dec102 of 10−8.3%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.